[Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)]

[Article in Japanese]

Review

[Article in Japanese]

Kenichi Koike et al. Rinsho Ketsueki. 2013 Jun.

. 2013 Jun;54(6):538-44.

No abstract available

Similar articles

[Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
Manabe A. Manabe A. Rinsho Ketsueki. 2012 Aug;53(8):729-33. Rinsho Ketsueki. 2012. PMID: 22975811 Review. Japanese. No abstract available.
Spontaneous remission of juvenile myelomonocytic leukemia with NRAS mutation.
Alsultan A, Khalifah M, Alrabiaah AA. Alsultan A, et al. Pediatr Hematol Oncol. 2012 Oct;29(7):624-6. doi: 10.3109/08880018.2012.710299. Epub 2012 Aug 2. Pediatr Hematol Oncol. 2012. PMID: 22857389 No abstract available.
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
Pérez B, Kosmider O, Cassinat B, Renneville A, Lachenaud J, Kaltenbach S, Bertrand Y, Baruchel A, Chomienne C, Fontenay M, Preudhomme C, Cavé H. Pérez B, et al. Br J Haematol. 2010 Dec;151(5):460-8. doi: 10.1111/j.1365-2141.2010.08393.x. Epub 2010 Oct 19. Br J Haematol. 2010. PMID: 20955399
[Molecular biology of juvenile myelomonocytic leukemia (JMML)].
Manabe A. Manabe A. Rinsho Ketsueki. 2010 Jul;51(7):526-31. Rinsho Ketsueki. 2010. PMID: 20693772 Review. Japanese. No abstract available.
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Chang TY, Dvorak CC, Loh ML. Chang TY, et al. Blood. 2014 Oct 16;124(16):2487-97. doi: 10.1182/blood-2014-03-300319. Epub 2014 Aug 27. Blood. 2014. PMID: 25163700 Review.

An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
Talati C, Padron E. Talati C, et al. Curr Hematol Malig Rep. 2016 Dec;11(6):425-433. doi: 10.1007/s11899-016-0350-1. Curr Hematol Malig Rep. 2016. PMID: 27664113 Review.